Using Human iPSC-Derived Peripheral Nervous System Disease Models for Drug Discovery

Handb Exp Pharmacol. 2023:281:191-205. doi: 10.1007/164_2023_690.

Abstract

Induced pluripotent stem cells (IPSCs), with their remarkable ability to differentiate into various cell types, including peripheral nervous system cells such as neurons and glial cells, offer an excellent platform for in vitro disease modeling. These iPSC-derived disease models have proven valuable in drug discovery, as they provide more precise simulations of a patient's disease state and allow for the assessment of potential therapeutic effectiveness and safety.

Keywords: Drug discovery, Induced pluripotent stem cell, Peripheral nervous system.

MeSH terms

  • Cell Differentiation
  • Drug Discovery
  • Humans
  • Induced Pluripotent Stem Cells*
  • Neurons
  • Peripheral Nervous System Diseases* / drug therapy
  • Peripheral Nervous System Diseases* / metabolism